EDAP TMS S.A. American Depositary Shares

FOCL

Medical - Devices · Healthcare

Exchange

NASDAQ Global Market

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

EDAP TMS is a French medical device company that makes machines used to treat prostate cancer and kidney stones without surgery. Its main product is the Focal One, a robotic device that uses high-intensity focused ultrasound (HIFU) to destroy cancer cells inside the body. Hospitals and urology clinics are its primary customers.

The company earns money by selling its devices to hospitals and charging ongoing fees for service contracts and disposable supplies used during each procedure. EDAP TMS operates mainly in Europe and the United States, and its small size — around $200 million in market value — means it is still in an early growth phase. The key growth driver is wider adoption of HIFU as an alternative to radiation or full prostate removal, but the main risk is that the company is currently losing money at a significant rate, which could require it to raise additional cash to keep operating.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-27.5% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-129.4% YoY

YoY Growth Rate

Earnings declining

Insider Activity

0.5%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~14 months

$23M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Adequate runway but may need to raise capital within 2 years

Revenue declining

EDAP TMS S.A. American Depositary Shares's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

55.6%

Premium pricing power — 55.6% gross margin

Profit after running costs

Operating Margin

-60.8%

Losing money on operations — -60.8%

Return on the money invested

ROCE

-22.4%

Weak — -22.4% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-28.1%

Burning cash (-28.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial